BWAY 15.31 ▲ 2.61% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BrainsWay Ltd.

    NASDAQ: BWAY · Real-Time Price · USD
    15.31
    0.39 (2.61%)
    At close: Oct 03, 2025, 3:59 PM
    15.31
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT
    2.61%
    Bid 14.5
    Market Cap 290.95M
    Revenue (ttm) 46.08M
    Net Income (ttm) 5.34M
    EPS (ttm) 0.28
    PE Ratio (ttm) 54.68
    Forward PE 55.26
    Analyst Buy
    Dividends n/a
    Ask 16.43
    Volume 48,623
    Avg. Volume (20D) 66,961
    Open 14.96
    Previous Close 14.92
    Day's Range 14.96 - 15.60
    52-Week Range 7.84 - 17.00
    Beta 0.25
    Ex-Dividend Date n/a

    About BWAY

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol BWAY
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for BWAY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    BrainsWay Ltd. is scheduled to release its earnings on Nov 11, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    +1.49%
    BrainsWay Closes $5M Convertible Note Loan Investm... Unlock content with Pro Subscription
    news image

    2 weeks ago · zacks.com

    BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care

    BrainsWay shares surge after the FDA cleared its accelerated Deep TMS protocol, offering faster depression treatment with strong clinical results.

    news image

    1 month ago · zacks.com

    BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care

    BrainsWay's $5 million investment in Neurolief expands its mental health footprint with at-home depression treatment potential.

    news image

    1 month ago · zacks.com

    Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?

    Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

    news image

    1 month ago · zacks.com

    Surging Earnings Estimates Signal Upside for Brainsway (BWAY) Stock

    Brainsway Ltd. Sponsored ADR (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

    news image

    1 month ago · zacks.com

    Wall Street Analysts Think Brainsway (BWAY) Could Surge 25.58%: Read This Before Placing a Bet

    The mean of analysts' price targets for Brainsway (BWAY) points to a 25.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys...

    news image

    1 month ago · seekingalpha.com

    BrainsWay Ltd. (BWAY) Q2 2025 Earnings Call Transcript

    BrainsWay Ltd. (NASDAQ:BWAY ) Q2 2025 Earnings Conference Call August 13, 2025 8:30 AM ET Company Participants Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Conference Call ...

    news image

    2 months ago · zacks.com

    Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns

    Let's take a look at four stocks, CPRX, GAMB, ORN and BWAY, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.

    Add to Watchlist